
Irving Investors
Description
Irving Investors is a Denver-based investment firm specializing in disruptive technology and high-growth opportunities. Operating primarily as a growth equity firm, Irving Investors strategically deploys capital into companies that have demonstrated significant market traction and are poised for substantial scaling. Their investment philosophy centers on identifying and backing innovative businesses across various technology sectors, including enterprise software, fintech, and consumer platforms, that are reshaping their respective industries.
The firm is known for its participation in later-stage funding rounds, typically from Series B onwards, often co-investing alongside prominent venture capital and growth equity firms. Their robust portfolio features a roster of highly successful and often unicorn-status companies, such as Stripe, Databricks, Snyk, Brex, Carta, and OpenSea. Irving Investors' involvement in these companies underscores their commitment to supporting market leaders and fast-growing innovators. For instance, they have participated in rounds that have reached monumental scales, including a Series G round for Databricks that secured over $1 billion.
Irving Investors' typical first check sizes reflect their focus on growth-stage companies requiring substantial capital for expansion. While specific figures can vary based on the opportunity and round dynamics, their initial investments generally range from $10 million to $75 million. This range enables them to provide meaningful capital injections to companies that are scaling rapidly and expanding their market reach. With a portfolio that includes at least 15 known investments, Irving Investors continues to be an active and influential player in the growth equity landscape, providing strategic support and capital to companies driving technological advancement.
Investor Profile
Irving Investors has backed more than 55 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 7% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Secondary Market, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, India, France.
- Strong thematic focus on Biotechnology, Health Care, E-Commerce.
- Typical check size: $10M – $75M.
Stage Focus
- Secondary Market (29%)
- Series C (16%)
- Series Unknown (9%)
- Series B (9%)
- Series D (9%)
- Series A (5%)
- Series F (5%)
- Series E (4%)
- Convertible Note (4%)
- Private Equity (2%)
Country Focus
- United States (91%)
- India (4%)
- France (2%)
- The Netherlands (2%)
- Germany (2%)
Industry Focus
- Biotechnology
- Health Care
- E-commerce
- Artificial Intelligence (Ai)
- Therapeutics
- Life Science
- Medical
- Software
- Biopharma
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.